Areas to Focus to Help Optimize Pediatric Patient Care and Revenue during 2024

As the healthcare landscape continues to evolve, pediatric practices must remain agile and proactive to provide the best care for their young patients. For 2024, it’s crucial for pediatric practice front desk teams to hone their focus on key areas to ensure a strong start to the new year. Let’s delve into the essential aspects…

Details

Winter Wellness: Navigating Pediatric Practice Challenges Amidst Seasonal Changes

Winter brings a host of seasonal changes that pediatric practice owners must navigate to ensure the well-being of their young patients. As the temperature drops and cold and flu season peaks, pediatric practices face unique challenges. In this article, we will explore some key strategies to promote winter wellness in your pediatric practice. Strengthening Preventive…

Details

Navigating the Holidays: Pediatric Practice Management Strategies for December

Introduction: As the holiday season approaches, pediatric practices must prepare for the unique challenges and opportunities that come with managing patient care, staff schedules, and overall practice operations. This time of year can be hectic for both families and healthcare professionals, but with thoughtful planning and strategic management, pediatric practices can ensure a smooth and…

Details

Navigating Pediatric Practice Management During Thanksgiving: Tips for Seamless Holiday Scheduling

As the Thanksgiving season approaches, pediatric practices must strategically manage their schedules to ensure a balance between providing quality care and allowing staff to enjoy the holiday festivities. Here are some essential considerations for pediatric practice management during Thanksgiving and the holiday season: 1. Early Communication: Begin by communicating with your staff well in advance. Discuss…

Details

Beyfortus (Nirsevimab) – RSV Prevention for Babies: Considerations for Pediatric Practice Managers and Leaders

Background The RSV prevention, Beyfortus (nirsevimab) which is a monoclonal antibody, was approved by the FDA on July 17, 2023.  The CDC and ACIP provided recommendations which were published in the MMWR on August 25, 2023. The FDA accelerated approval of Beyfortus since the RSV prevention was categorized as “Breakthrough Therapy Designation”.  Note that Beyfortus…

Details